Stock · DXCM · Drug & medical companies
Members of Congress trading DexCom, Inc. (DXCM)
4 members of Congress reported 9 trades in DexCom, Inc. (DXCM) since January 2025: 4 purchases and 5 sales, worth $249K to $710K in total. Rep. Robert P. Bresnahan, Jr. traded it most, 3 times. The latest reported trade was on May 7, 2026.
- Members who traded it
- 4
- Trades since 2025
- 9
- Purchases
- 4
- Sales
- 5
- Reported value
- $249K–$710K
- Democrats / Republicans
- 1 / 3
Who in Congress trades it
- Rep. Robert P. Bresnahan, Jr. R-PA-83 trades
- Rep. Jefferson Shreve R-IN-63 trades
- Sen. Tina Smith D-MN2 trades
- Sen. John Boozman R-AR1 trade
Latest trades
- Sen. Tina Smith sold (Spouse)May 7, 2026 · $100K–$250K
- Sen. Tina Smith sold (Spouse)Apr 29, 2026 · $100K–$250K
- Sen. John Boozman bought (Joint)Jan 26, 2026 · $1,001–$15K
- Rep. Robert P. Bresnahan, Jr. boughtMay 15, 2025 · $1,001–$15K
- Rep. Jefferson Shreve soldMay 12, 2025 · $15K–$50K
- Rep. Jefferson Shreve boughtMay 8, 2025 · $15K–$50K
- Rep. Robert P. Bresnahan, Jr. soldApr 8, 2025 · $1,001–$15K
- Rep. Jefferson Shreve soldApr 7, 2025 · $15K–$50K
- Rep. Robert P. Bresnahan, Jr. boughtFeb 25, 2025 · $1,001–$15K
About these numbers
Members of Congress must report stock trades by themselves, their spouses and dependent children within 45 days, in dollar ranges rather than exact amounts. Trading stock is legal. This page lists trades reported on House and Senate periodic transaction reports since January 1, 2025, as of Oct 17, 2026.
Related
From House Clerk and Senate disclosure reports. Each member’s profile links to the original filings.
Cite or embed this page
Capitol Receipts, “DexCom (DXCM) Stock Trades by Members of Congress,” https://www.capitolreceipts.com/stock/DXCM/dexcom-inc (accessed 2026-10-17).